Sign in

CIK 0001645460

  • Non-accelerated filer
  • Smaller reporting company

Cue Biopharma, Inc.

Sign in to watch
Ticker
CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473324577
Phone
+1 617-949-2680
Business address
100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
Former names
Imagen Biopharma, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Director bought 18,521 shares at $4.64 ($85,937)
  9. 4 Open-market buy Director bought 7,000 shares at $4.62 ($32,340)
  10. 4 Open-market buy Director bought 20,000 shares at $4.77 ($95,400)
  11. 4 Open-market buy Director bought 19,647 shares at $4.29 ($84,286)
  12. 4 Open-market buy Chief Scientific Officer bought 2,000 shares at $4.37 ($8,740)
  13. 4 Open-market buy Director bought 17,200 shares at $4.53 ($77,916)
  14. 4 Open-market buy Director bought 10,000 shares at $4.49 ($44,900)
  15. 4 Open-market buy Director bought 9,438 shares at $4.74 ($44,736)
  16. 4 Open-market buy Director bought 400 shares at $5.00 ($2,000)
  17. 4 Open-market buy Director bought 3,664 shares at $5.20 ($19,053)
  18. 4 Open-market buy Director bought 10,000 shares at $5.48 ($54,800)
  19. 4 Open-market buy Director bought 10,000 shares at $5.06 ($50,600)
  20. 4 Open-market buy Director bought 12,189 shares at an average $5.08 ($61,978)

Page 11 of 13 · 259 filings